Organization · Venture Capital
Zoic Capital
Zoic Capital is a US-based venture capital firm founded in 2014, specializing in early-stage healthcare innovations at the intersection of life sciences and medical technology. The firm focuses on investing in startups with strong intellectual property and transformative technologies.
Overview
What Zoic Capital does
What Zoic Capital is
Zoic Capital is a US-based venture capital firm founded in 2014, specializing in early-stage healthcare innovations at the intersection of life sciences and medical technology. The firm focuses on investing in startups with strong intellectual property and transformative technologies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2014
- Approximate age
- About 12 years
- Structured capabilities
- Funder
- Last reviewed
- April 22, 2026
Official channels
Find Zoic Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Zoic Capital as a funder
Investment thesis
Zoic Capital addresses the systematic underfunding of early-stage health technology startups by investing in ventures that leverage hard science and possess strong intellectual property.
Focus narrative
Zoic Capital invests in ventures from Seed to Series A stages, concentrating on the first three rounds of capital. The firm targets frontier technologies that are backed by robust intellectual property and address well-defined problems with measurable impacts. Their investment thesis emphasizes the importance of market validation and the potential for transformative technologies.
Value beyond capital
Zoic Capital provides portfolio companies with access to a network of venture partners who offer clinical and operational expertise, enhancing the development and market readiness of their innovations.
Terms and economics
- Typical check
- $500,000–$10,000,000
Focus and fit
- Stages
- Seed · Series A · Growth Equity
- Sectors
- Healthcare · Biotech · Medical Devices · Digital Health
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
Portfolio context
Notable portfolio companies include HDT Bio, a biopharma company, and ChromaTan Technologies, which focuses on continuous bioprocessing for biologics purification. Additional medical technology companies are also part of their portfolio.
Common questions
What to know about Zoic Capital
Upseed classifies Zoic Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 22, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.